Acadia Healthcare Company, Inc. (ACHC) P/E Ratio History
Historical price-to-earnings valuation from 2012 to 2025
Loading P/E history...
ACHC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 7, 2026, Acadia Healthcare Company, Inc. (ACHC) trades at a price-to-earnings ratio of -2.1x, with a stock price of $25.30 and trailing twelve-month earnings per share of $-12.18.
The current P/E is 110% below its 5-year average of 20.7x. Over the past five years, ACHC's P/E has ranged from a low of 13.6x to a high of 28.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, ACHC trades at a 109% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, ACHC trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ACHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ACHC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $11B | 7.3 | 0.46 | +37% | |
| $2B | 13.9 | - | -29% | |
| $10B | 30.1 | 2.18 | +14% | |
| $96B | 15.1 | 0.72 | +29% | |
| $17B | 12.6 | 0.38Best | -53% | |
| $404M | 0.8Lowest | - | +197%Best | |
| $111B | 62.5 | - | -62% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ACHC Historical P/E Data (2012–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $24.76 | $1.17 | 21.2x | -68% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $22.69 | $1.51 | 15.0x | -77% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $30.32 | $2.03 | 14.9x | -77% |
| FY2024 Q4 | $39.65 | $2.77 | 14.3x | -78% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $63.41 | $3.05 | 20.8x | -68% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $79.64 | $2.96 | 26.9x | -59% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $72.25 | $3.05 | 23.7x | -64% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $82.32 | $3.00 | 27.4x | -58% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $78.18 | $3.10 | 25.2x | -61% |
| FY2022 Q2 | $67.63 | $3.05 | 22.2x | -66% | |
| FY2022 Q1 | $65.53 | $2.66 | 24.6x | -62% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $60.70 | $2.10 | 28.9x | -56% |
Average P/E for displayed period: 65.2x
See ACHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACHC — Frequently Asked Questions
Quick answers to the most common questions about buying ACHC stock.
Is ACHC stock overvalued or undervalued?
ACHC trades at -2.1x P/E, below its 5-year average of 20.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ACHC's valuation compare to peers?
Acadia Healthcare Company, Inc. P/E of -2.1x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is ACHC's PEG ratio?
ACHC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2012-2025.